Ocular Therapeutix Inc. | Ownership
Companies that own Ocular Therapeutix Inc.
Fidelity Management & Research Co.
3,239,448
8.39%
0
0%
06/30/2018
Summer Road LLC
3,027,488
7.85%
0
67.53%
06/30/2018
Jennison Associates LLC
2,319,255
6.01%
26,503
0.01%
06/30/2018
BlackRock Fund Advisors
1,804,641
4.68%
220,939
0%
06/30/2018
Wellington Management Co. LLP
1,513,007
3.92%
63,142
0%
06/30/2018
The Vanguard Group, Inc.
1,271,716
3.3%
-21,218
0%
06/30/2018
Opaleye Management, Inc.
1,111,000
2.88%
0
1.89%
06/30/2018
Deltec Asset Management LLC
532,986
1.38%
-53,253
0.7%
06/30/2018
SSgA Funds Management, Inc.
432,980
1.12%
59,057
0%
06/30/2018
Northern Trust Investments, Inc.
362,627
0.94%
38,101
0%
06/30/2018
| Address |
15 Crosby Drive
Bedford Massachusetts 01730
United States
|
|
Employees
|
- |
| Website |
http://www.ocutx.com |
| Updated |
07/08/2019 |
| Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline include Dextenza, OTX-TP, and OTX-TIC . The company was founded by Amarpreet S. |
